{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:41:03Z","timestamp":1761154863594},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ygyno.2006.01.031","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T07:25:10Z","timestamp":1140593110000},"page":"72-74","source":"Crossref","is-referenced-by-count":10,"title":["Elevated body mass index does not increase the risk of palmar\u2013plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin"],"prefix":"10.1016","volume":"103","author":[{"given":"Mary E.","family":"Gordinier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don S.","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn L.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Weitzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn P.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.O.","family":"Granai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2006.01.031_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2006.01.031_bib2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/sj.bjc.6600250","article-title":"A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin, and paclitaxel in ovarian cancer","volume":"86","author":"Gibbs","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"Suppl 9","key":"10.1016\/j.ygyno.2006.01.031_bib3","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0959-8049(01)00329-X","article-title":"Caelyx: phase II studies in ovarian cancer","volume":"37","author":"Johnston","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.031_bib4","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.031_bib5","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2000.18.17.3093","article-title":"Phase II study of liposomal doxorubicin in platinum and paclitaxel refractory epithelial ovarian cancer","volume":"18","author":"Gordon","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.031_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0169-409X(96)00476-0","article-title":"Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals","volume":"24","author":"Gabizon","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ygyno.2006.01.031_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2004.02.019","article-title":"The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma","volume":"93","author":"Molpus","year":"2004","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T21:50:56Z","timestamp":1555451456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0090825806000618"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.01.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}